U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H9Br
Molecular Weight 137.018
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUTYL BROMIDE

SMILES

CCCCBr

InChI

InChIKey=MPPPKRYCTPRNTB-UHFFFAOYSA-N
InChI=1S/C4H9Br/c1-2-3-4-5/h2-4H2,1H3

HIDE SMILES / InChI
Molecular Formula C4H9Br
Molecular Weight 137.018
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Butyl bromide (or 1-Bromobutane), an organic compound that is used as an intermediate in organic synthesis and as a solvent for cleaning and degreasing.

Approval Year

Unknown
149124
PubMed

PubMed

TitleDatePubMed
Role of glutathione conjugation in 1-bromobutane-induced hepatotoxicity in mice.
2010-10
A new gastric-emptying mouse model based on in vivo non-invasive bioluminescence imaging.
2010-10
Covalent synthesis of organophilic chemically functionalized graphene sheets.
2010-08-15
Effect of hyoscine butylbromide (HBB) on the uterine corpus: quantitative assessment with T2-weighted (T2W) MRI in healthy volunteers.
2010-08
Cyclic carbonate synthesis catalysed by bimetallic aluminium-salen complexes.
2010-06-18
A systematic review of the treatment of nausea and/or vomiting in cancer unrelated to chemotherapy or radiation.
2010-04
Compatibility and stability of ternary admixtures of tramadol, haloperidol, and hyoscine N-butyl bromide: retrospective clinical evaluation.
2010-03
The ACB technique: a biomagentic tool for monitoring gastrointestinal contraction directly from smooth muscle in dogs.
2010-02
Ultrasound-assisted third-liquid phase-transfer catalyzed esterification of sodium salicylate in a continuous two-phase-flow reactor.
2010-01
Exacerbation of facial motoneuron loss after facial nerve axotomy in CCR3-deficient mice.
2009-12-11
A substrate-independent approach for bactericidal surfaces.
2009-12
A case of acute post-laparoscopy bowel hypermotility and treatment with hyoscine butylbromide.
2009-12
Reducing gastric secretions--a role for histamine 2 antagonists or proton pump inhibitors in malignant bowel obstruction?
2009-12
Validation of a liquid chromatographic/tandem mass spectrometric method for the determination of scopolamine butylbromide in human plasma: application of the method to a bioequivalence study.
2009-11-18
Calorimetric determination of the enthalpy of 1-butyl-3-methylimidazolium bromide synthesis: a key quantity in thermodynamics of ionic liquids.
2009-11-05
Fixed drug eruption resulting from fluconazole use: a case report.
2009-07-06
Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care.
2009-07
Aperistaltic effect of hyoscine N-butylbromide versus glucagon on the small bowel assessed by magnetic resonance imaging.
2009-06
Reichardt's dye and its reactions with the alkylating agents 4-chloro-1-butanol, ethyl methanesulfonate, 1-bromobutane and Fast Red B - a potentially useful reagent for the detection of genotoxic impurities in pharmaceuticals.
2009-04
Electrical and mechanical effects of hyoscine butylbromide on the human stomach: a non-invasive approach.
2009-04
Multidisciplinary functional MR imaging for prostate cancer.
2009-02-19
Hyoscine butylbromide potently blocks human nicotinic acetylcholine receptors in SH-SY5Y cells.
2009-02-06
Efficacy of barium-based fecal tagging for CT colonography: a comparison between the use of high and low density barium suspensions in a Korean population - a preliminary study.
2009-02-03
Pegaptanib Sodium versus Pegaptanib Sodium Combined with Macular Laser Photocoagulation or Laser Alone for Diabetic Macular Edema.
2009
Multiple cutaneous leiomyomas: pain relief with pulsed hysocine butyl bromide.
2009
Total synthesis of the natural succinate derivative of 5-(hydroxymethyl)furfural isolated from the Noni fruit (Morinda citrifolia).
2009
Scopolamine-induced migraine like headache.
2009
Hyoscine butylbromide - a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures.
2008-11
An audit of analgesia requirements for high-dose-rate prostate brachytherapy.
2008-09
Spectrophotometric determination of hyoscine butylbromide and famciclovir in pure form and in pharmaceutical formulations.
2008-09
The effect of hyoscine butyl bromide on the first stage of labour in term pregnancies.
2008-07
Re: the value of hyoscine butylbromide in pelvic MRI.
2008-07
Tramadol as a prophylactic analgesic for hysterosalpingography in African women.
2008-06
Role of hyoscine N-butyl bromide (HBB, buscopan) as labor analgesic.
2008-05
Management of malignant bowel obstruction.
2008-05
Interventions for noisy breathing in patients near to death.
2008-01-23
The effect of hyoscine butylbromide on the first stage of labour in term pregnancies.
2007-12
Metabolism before, during and after anaesthesia in colic and healthy horses.
2007-11-15
The value of hyoscine butylbromide in pelvic MRI.
2007-11
Synthesis of novel lactam derivatives and their evaluation as ligands for the dopamine receptors, leading to a D(4)-selective ligand.
2007-09-01
Fundamental elements for successful performance of CT colonography (virtual colonoscopy).
2007-08-04
Concomitant pulmonary and hepatic toxicity secondary to nitrofurantoin: a case report.
2007-08-01
Unexpected anterograde amnesia associated with Buscopan used as a predmedication for endocscopy.
2007-07-28
Management of acute diarrhoea in primary care in Bahrain: self-reported practices of doctors.
2007-06
Effects of Spascupreel versus hyoscine butylbromide for gastrointestinal cramps in children.
2007-06
Formation of scopolamine from N-butyl-scopolammonium bromide in cigarettes.
2007-05
Development of membrane electrodes for the selective determination of hyoscine butylbromide.
2007-04-30
Role of intravenously administered hyoscine butyl bromide in retrograde terminal ileoscopy: a randomized, double-blinded, placebo-controlled trial.
2007-03-28
Synthesis of cationic single-isomer cyclodextrins for the chiral separation of amino acids and anionic pharmaceuticals.
2007
Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain.
2007
Patents

Patents

03943098
1
03951959
1
04006123
3
04022802
1
04128720
2
04172890
1
04284641
7
04377522
3
04444766
1
04732998
1
04826869
5
04917817
1
04931444
2
04973648
1
05026913
1
05166398
1
05175340
1
05328920
1
05334716
5
05360886
1
05412102
1
05554663
1
05631405
1
06100272
1
06174961
1
06232290
2
06342610
3
06703392
4
06867333
1
06946481
11
07022730
1
07081455
1
07138391
1
07176242
3
07319099
1
07528124
1
07718999
1
07763639
3
07902203
4
07939661
2
08026365
1
08026370
2
08030354
4
08063046
1
08097634
1
08173687
1
08216489
1
08269000
1
08298632
1
08329620
1
08466188
3
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:45:49 GMT 2025
Edited
by admin
on Mon Mar 31 18:45:49 GMT 2025
Record UNII
SAV6Y78U3D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
N-BUTYL BROMIDE
HSDB   MI  
Preferred Name English
BUTYL BROMIDE
Systematic Name English
N-BUTYL BROMIDE [MI]
Common Name English
N-BUTYLBROMIDE
Common Name English
BUTANE, 1-BROMO-
Systematic Name English
N-BUTYL BROMIDE [HSDB]
Common Name English
1-BROMOBUTANE
Systematic Name English
Code System Code Type Description
WIKIPEDIA
1-BROMOBUTANE
Created by admin on Mon Mar 31 18:45:49 GMT 2025 , Edited by admin on Mon Mar 31 18:45:49 GMT 2025
PRIMARY
HSDB
2195
Created by admin on Mon Mar 31 18:45:49 GMT 2025 , Edited by admin on Mon Mar 31 18:45:49 GMT 2025
PRIMARY
EVMPD
SUB118553
Created by admin on Mon Mar 31 18:45:49 GMT 2025 , Edited by admin on Mon Mar 31 18:45:49 GMT 2025
PRIMARY
ECHA (EC/EINECS)
203-691-9
Created by admin on Mon Mar 31 18:45:49 GMT 2025 , Edited by admin on Mon Mar 31 18:45:49 GMT 2025
PRIMARY
CAS
109-65-9
Created by admin on Mon Mar 31 18:45:49 GMT 2025 , Edited by admin on Mon Mar 31 18:45:49 GMT 2025
PRIMARY
PUBCHEM
8002
Created by admin on Mon Mar 31 18:45:49 GMT 2025 , Edited by admin on Mon Mar 31 18:45:49 GMT 2025
PRIMARY
FDA UNII
SAV6Y78U3D
Created by admin on Mon Mar 31 18:45:49 GMT 2025 , Edited by admin on Mon Mar 31 18:45:49 GMT 2025
PRIMARY
EPA CompTox
DTXSID6021903
Created by admin on Mon Mar 31 18:45:49 GMT 2025 , Edited by admin on Mon Mar 31 18:45:49 GMT 2025
PRIMARY
MERCK INDEX
m2825
Created by admin on Mon Mar 31 18:45:49 GMT 2025 , Edited by admin on Mon Mar 31 18:45:49 GMT 2025
PRIMARY Merck Index
MESH
C047757
Created by admin on Mon Mar 31 18:45:49 GMT 2025 , Edited by admin on Mon Mar 31 18:45:49 GMT 2025
PRIMARY
SMS_ID
100000143024
Created by admin on Mon Mar 31 18:45:49 GMT 2025 , Edited by admin on Mon Mar 31 18:45:49 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966